Wagner D-C, Roth W
Institut für Pathologie, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Langenbeckstr. 1, 55131, Mainz, Deutschland.
Pathologe. 2018 Nov;39(6):532-538. doi: 10.1007/s00292-018-0541-8.
The quantity, distribution, activation status, cytokine profile, and spatial distribution of tumor-infiltrating immune cells have prognostic value and may be predictive of response to immunotherapies.
A survey of relevant immune cell populations including their prognostic significance in the most common types of tumors.
Nonsystematic assessment and a discussion of studies that were conducted to estimate the prognostic significance of certain immune cell subsets and the methodical approaches used.
For many tumor entities, prognostically favorable and unfavorable immune cell populations can be differentiated. However, nonspecific cell markers that may partly summarize antithetic immune cell subsets can be employed. Differences in sampling procedures and the determination of cut-off levels further limit the comparability of the studies carried out so far.
The phenotypic and functional heterogeneity of tumor-infiltrating immune cells requires the use of cell subset-specific antibodies and antibody combinations. Furthermore, harmonized assessment routines, validation studies, and meta-analyses are important prerequisites for potential diagnostic implementation.
肿瘤浸润免疫细胞的数量、分布、激活状态、细胞因子谱以及空间分布具有预后价值,并且可能预测对免疫疗法的反应。
对相关免疫细胞群体进行调查,包括它们在最常见肿瘤类型中的预后意义。
对为评估某些免疫细胞亚群的预后意义而开展的研究以及所采用的方法学途径进行非系统性评估和讨论。
对于许多肿瘤实体,可以区分出预后良好和不良的免疫细胞群体。然而,可以采用可能部分概括对立免疫细胞亚群的非特异性细胞标志物。采样程序和临界值确定方面的差异进一步限制了迄今所开展研究的可比性。
肿瘤浸润免疫细胞的表型和功能异质性需要使用细胞亚群特异性抗体和抗体组合。此外,统一的评估程序、验证研究和荟萃分析是潜在诊断应用的重要前提条件。